No free passes: FDA tightens rule against Foreign Tobacco Manufactures

Date:

Share post:

The U.S. Food and Drug Administration (FDA)  issued a proposed rule aimed at strengthening oversight of foreign tobacco product manufacturers and blocking illegal products from entering the United States.

The proposed rule, titled “Establishment Registration and Product Listing for Tobacco Products,” would eliminate existing regulatory gaps by requiring foreign tobacco manufacturers to register their establishments and list their products with the FDAstandard,already required for domestic companies.

By implementing these uniform requirements, the FDA aims to proactively identify and intercept unauthorized tobacco imports, with a specific focus on youth-appealing, illicit e-cigarettes. The rule will also enhance the agency’s ability to conduct systematic, on-site compliance inspections of manufacturing facilities located outside the United States.

Under the new framework, manufacturers must electronically submit granular product details, including nicotine concentrations, e-liquid volumes, battery capacities, and characterizing flavors. Additionally, companies will be required to maintain comprehensive labeling and advertising records for at least four years to ensure public health compliance.

The public is invited to submit comments on the proposed rule until September 14, 2026.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...